June 10, 2009Open Access

Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis

Key Points

Key points are not available for this paper at this time.

Abstract

In a large cohort of patients with clinically localized prostate cancer who were managed with one of five primary modalities, the CAPRA score predicted clinical prostate cancer endpoints with good accuracy. These results support the value of the CAPRA score as a risk assessment and stratification tool for both research studies and clinical practice.

Read Full Paperexternally

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Cooperberg et al. (Wed,) studied this question.

synapsesocial.com/papers/69dbdb1150e1971baba3d17f https://doi.org/https://doi.org/10.1093/jnci/djp122

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prostate cancer risk assessment2008 · 18 citations
2Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy2005 · 1,358 citations
3Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes2007 · 841 citations
4Cancer Statistics, 20082008 · 10,201 citations
5The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement1993 · 499 citations

AI에게 질문

Bookmark

View Full Paper